Description
An inhibitor of HPPD; increases urinary levels of HPPA and HPLA in rats at 10 mg/kg; prevents the neonatal lethality of FAH deficiency in mice when administered to pregnant dams at 3 mg/kg; exhibits hepatoprotective effects in FAH-/- mice, such as prevention of increases in plasma levels of AST and conjugated bilirubin, when administration is continued following birth at 1 mg/kg; decreases urinary excretion of homogentisate and increases urinary excretion of HPPA, HPLA, and 4-hydroxyphenylacetate in a mouse model of ethylnitrosourea-induced alkaptonuria at 100 μg
Formal name: 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione
Synonyms: NTBC|SC-0735
Molecular weight: 329.2
CAS: 104206-65-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Amino Acid Turnover||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Plant Biology|Phytotoxins